Bill Text: DE HB374 | 2017-2018 | 149th General Assembly | Engrossed


Bill Title: An Act To Amend Title 16 Of The Delaware Code Relating To The Medical Marijuana Act.

Spectrum: Moderate Partisan Bill (Democrat 19-5)

Status: (Passed) 2018-08-28 - Signed by Governor [HB374 Detail]

Download: Delaware-2017-HB374-Engrossed.html

SPONSOR:

Rep. Schwartzkopf & Rep. Potter & Sen. Lopez & Sen. Townsend

Reps. Baumbach, Bentz, Bolden, Heffernan, Hudson, Jaques, Q. Johnson, Kowalko, Mitchell, Osienski, Outten, Paradee, B. Short, Spiegelman, Viola, K. Williams; Sens. Delcollo, Henry, Marshall, Sokola

HOUSE OF REPRESENTATIVES

149th GENERAL ASSEMBLY

HOUSE BILL NO. 374

AS AMENDED BY

HOUSE AMENDMENT NO. 1

AN ACT TO AMEND TITLE 16 OF THE DELAWARE CODE RELATING TO THE MEDICAL MARIJUANA ACT.

BE IT ENACTED BY THE GENERAL ASSEMBLY OF THE STATE OF DELAWARE:

Section 1. Amend Section 4902A, Title 16 of the Delaware Code by making deletions as shown by strike through and insertions as shown by underline as follows:

§ 4902A. Definitions.

In this chapter, unless the context otherwise requires, the following definitions shall apply:

(3) "Debilitating medical condition'' means 1 or more of the following:

a. Terminal illness, cancer, positive status for human immunodeficiency virus, acquired immune deficiency syndrome, decompensated cirrhosis, amyotrophic lateral sclerosis, agitation of Alzheimer's disease, post-traumatic stress disorder, intractable epilepsy, seizure disorder, glaucoma, chronic debilitating migraines, or the treatment of these conditions.

b. A chronic or debilitating disease or medical condition or its treatment that produces 1 or more of the following: cachexia or wasting syndrome; severe, debilitating pain that has not responded to previously prescribed medication or surgical measures for more than 3 months or for which other treatment options produced serious side effects; intractable nausea; seizures; severe and persistent muscle spasms, including those characteristic of multiple sclerosis.

c. Any other medical condition or its treatment added by the Department, as provided for in § 4906A of this title.

feedback